(Q44988720)

English

Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection

scientific article published on October 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

1 reference

based on heuristic

inferred from title

author name string

R. N. Husson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

Y. Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

J. Mordenti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

K. M. Butler

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

S. Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

A. M. Duliege

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

P. Brouwers

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

P. Jarosinski

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

B. U. Mueller

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

A. Ammann

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1357124

17 September 2022

language of work or name

0 references

publication date

1 October 1992

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

627-633

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

The CD4 antigen: physiological ligand and HIV receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Designing CD4 immunoadhesins for AIDS therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

Complications of central venous catheters in pediatric patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981161-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3476(05)81161-8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44988720&oldid=1892555902"